Repaglinide
Repaglinide is a short-acting insulin secretagogue used for selected type 2 diabetes.
Key points
- Its glucose-lowering effect is linked to meals and missed meals can increase hypoglycaemia risk.
- Some medicines can greatly increase exposure.
- Severe low glucose or loss of consciousness is an emergency.
Listings are for comparison and general information; suitability and supply depend on clinician and pharmacy checks, monitoring and prescription requirements.
Important safety checks
Meal pattern, liver and kidney function, other diabetes medicines and major interactions require review.
When to seek urgent care
Seek urgent help for confusion, seizures, loss of consciousness or low glucose that does not improve promptly.
